More from The Hollywood Reporter Bain's Advice For Hollywood This Year ... And then on Sunday, Feb. 9, she was to have made the drive up to Santa Barbara to be feted as one of this year’s nine ...

“It now calls for those offering themselves to generate some degree ... In Polling Division 6 (Pelican Point and McLean’s Town) Daniel Bain, 38 votes; Kendal Leathen 55 votes and Geno Thomas received ...

Lisa Bain Ministries has been spreading hope to cancer patients, veterans, children in crisis, and those experiencing ...

Bain Capital is making a play for full control of Surgery Partners (NASDAQ:SGRY), throwing down a $25.75 per share all-cash offervaluing the surgical facility operator at $3.2 billion. With Bain ...

U.S. investment fund Bain Capital may not launch a tender offer for Japanese system developer Fuji Soft, sources said. In a statement released Monday, Bain said that it is "carefully considering ...

Jan 28 (Reuters) - Bain Capital Private Equity has proposed to acquire the remaining shares of surgical facility operator Surgery Partners (SGRY.O), opens new tab it does not already own for $25. ...

Read: A tale of two consultants: First Bain, now McKinsey, in state capture dock [Oct 2022] The Treasury has filed a notice to oppose Bain’s application and will focus on the constitutional ...

Bain Capital has promoted Ivano Sessa to be co-head of European private equity as the investment firm is shaking up its leadership ranks in the region. The 47-year-old Italian will help lead the ...

Brookfield offered A$4.60 per share for Insignia and has been granted limited access to its books, according to a statement ...

TOKYO -- Japan's Mitsubishi Chemical Group has granted a first-refusal right to U.S. investment fund Bain Capital for the purchase of its pharmaceutical subsidiary Mitsubishi Tanabe Pharma ...

Diversity, equity and inclusion programs were created to help communities that have historically faced obstacles ...

Private equity firm Bain Capital agreed to acquire Mitsubishi Chemical Group’s pharmaceutical unit, adding to a dealmaking boom in Japan. The deal values Mitsubishi Tanabe Pharma at about ¥510 ...